DOI: 10.1055/s-00000134

Diabetologie und Stoffwechsel

References

Nissen SE, Wolski K, Topol EJ.
Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus.

JAMA 2005;
294: 2581-2586

Download Bibliographical Data

Access: